You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

Details for Patent: 11,097,007


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,097,007
Title:Injectable preparation
Abstract:An object of the present invention is to provide a storage-stable injectable preparation comprising a composition comprising a poorly soluble drug as an active ingredient and a dispersion medium. Another object of the present invention is to provide a compact, lightweight prefilled syringe by filling a syringe with the injectable preparation. The present invention provides an injectable preparation comprising a composition comprising a poorly soluble drug, a dispersion medium, and a specific suspending agent, the composition having a viscosity of 40 pascal-seconds or more in at least one point in the shear rate range of 0.01 to 0.02 sand having a viscosity of 0.2 pascal-seconds or less in at least one point in the shear rate range of 900 to 1,000 s, as measured.
Inventor(s):Kaneko Daiki, Matsuda Takakuni, Hoshika Yusuke
Assignee:OTSUKA PHARMACEUTICAL CO., LTD.
Application Number:US17108939
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 11,097,007

Introduction

The United States Patent 11,097,007, titled "Injectable Preparation," is a patent that covers a specific invention related to pharmaceutical formulations. To delve into the details of this patent, it is crucial to analyze its scope, claims, and the broader patent landscape.

Patent Overview

The patent in question, US11097007B2, pertains to an injectable preparation comprising a composition that includes a poorly soluble drug, a dispersion medium, and specific additives to enhance the formulation's stability and efficacy[4].

Scope of the Patent

Definition of Scope

The scope of a patent is defined by its claims, which outline the boundaries of what is protected by the patent. The scope is a critical aspect in determining the patent's validity, enforceability, and potential for litigation[3].

Key Components of the Patent Scope

  • Poorly Soluble Drug: The patent focuses on formulations that incorporate drugs with poor solubility, which is a common challenge in pharmaceutical development.
  • Dispersion Medium: The use of a specific dispersion medium is essential to ensure the drug's stability and bioavailability.
  • Additives: The patent specifies certain additives that are crucial for maintaining the formulation's viscosity, particle diameter, and concentration, all of which are vital for the injectable preparation's effectiveness[4].

Claims Analysis

Independent and Dependent Claims

The patent includes both independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims build upon the independent claims and provide additional details or limitations.

  • Independent Claims: These claims define the core invention, such as the composition of the injectable preparation and its key components.
  • Dependent Claims: These claims specify additional features or limitations, such as the concentration of the drug, the type of dispersion medium, and the properties of the additives[4].

Claim Language and Scope

The language used in the claims is precise and technical, ensuring that the scope of the patent is clearly defined. For instance, the claims might specify the particle diameter range or the viscosity of the dispersion medium, which are critical for the formulation's stability and efficacy.

Patent Landscape

Related Patents and Prior Art

The patent landscape includes other patents and prior art that relate to injectable preparations and pharmaceutical formulations. Understanding this landscape is essential for assessing the novelty and non-obviousness of the invention.

  • Prior Art: The prior art keywords listed in the patent, such as "injectable preparation," "salt," "viscosity," and "particle diameter," indicate the existing knowledge in the field and help in distinguishing the current invention from previous works[4].

Expiration Dates and Patent Term Adjustments

The patent's expiration date and any patent term adjustments (PTA) or extensions (PTE) are crucial for understanding its lifespan and potential impact on the market.

  • Expiration Date: The patent's expiration date is typically 20 years from the filing date, unless there are any PTA or PTE that extend its term[2].

Inventorship and Ownership

Determining Inventorship

Inventorship is a critical aspect of patent law, and it is defined by who conceived the idea or ideas of the patent claims. For the US11097007B2 patent, the inventors listed are those who conceived the specific composition and formulation of the injectable preparation[1].

Ownership and Assignment

The patent's ownership and any assignments or licenses are important for understanding who has the rights to the invention and how it can be used or licensed.

Enforceability and Litigation

Validity and Infringement

The enforceability of the patent depends on its validity, which can be challenged based on grounds such as obviousness, novelty, and non-obviousness. Any infringement claims would need to be assessed against the specific claims of the patent[2].

Deceptive Intent and Correcting Inventorship

Errors in inventorship can lead to significant legal issues, including the invalidation of the patent if there was deceptive intent. Ensuring accurate inventorship is vital for maintaining the patent's enforceability[1].

Metrics for Measuring Patent Scope

Independent Claim Length and Count

Research has shown that metrics such as independent claim length and count can be used to measure patent scope. These metrics can provide insights into the breadth and clarity of the patent claims, which are important for assessing patent quality[3].

Conclusion and Key Takeaways

  • Clear Claims: The patent's claims are precise and technical, defining the core invention and its key components.
  • Scope Definition: The scope is determined by the claims, which outline the boundaries of what is protected.
  • Patent Landscape: Understanding related patents and prior art is essential for assessing novelty and non-obviousness.
  • Inventorship: Accurate determination of inventorship is crucial for the patent's enforceability.
  • Enforceability: The patent's validity and potential for infringement are key factors in its enforceability.

Key Takeaways

  • The US11097007B2 patent is specific to injectable preparations with poorly soluble drugs.
  • The claims define the composition, dispersion medium, and additives.
  • Understanding the patent landscape is vital for assessing the invention's novelty.
  • Accurate inventorship is essential for the patent's enforceability.
  • Metrics like independent claim length and count can help measure patent scope.

Frequently Asked Questions (FAQs)

What is the main focus of the US11097007B2 patent?

The main focus of the US11097007B2 patent is an injectable preparation comprising a composition that includes a poorly soluble drug, a dispersion medium, and specific additives.

How is the scope of a patent defined?

The scope of a patent is defined by its claims, which outline the boundaries of what is protected by the patent.

What are the key components of the injectable preparation in this patent?

The key components include a poorly soluble drug, a dispersion medium, and specific additives to enhance stability and efficacy.

Why is accurate inventorship important?

Accurate inventorship is crucial for the patent's enforceability, as errors can lead to the invalidation of the patent if there was deceptive intent.

How can the scope of a patent be measured?

Metrics such as independent claim length and count can be used to measure patent scope, providing insights into the breadth and clarity of the patent claims.

Cited Sources

  1. Determining Inventorship for US Patent Applications - Oregon State University
  2. ALLERGAN USA, INC. v. MSN LABORATORIES PRIVATE LTD. - Court of Appeals for the Federal Circuit
  3. Patent Claims and Patent Scope - SSRN
  4. US11097007B2 - Injectable preparation - Google Patents
  5. U.S. Patent and Trademark Office (USPTO) - USA.gov

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 11,097,007

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Otsuka ABILIFY ASIMTUFII aripiprazole SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 217006-001 Apr 27, 2023 RX Yes No 11,097,007 ⤷  Subscribe Y MAINTENANCE MONOTHERAPY TREATMENT OF BIPOLAR I DISORDER ⤷  Subscribe
Otsuka ABILIFY ASIMTUFII aripiprazole SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 217006-001 Apr 27, 2023 RX Yes No 11,097,007 ⤷  Subscribe Y TREATMENT OF SCHIZOPHRENIA ⤷  Subscribe
Otsuka ABILIFY ASIMTUFII aripiprazole SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 217006-002 Apr 27, 2023 RX Yes Yes 11,097,007 ⤷  Subscribe Y TREATMENT OF SCHIZOPHRENIA ⤷  Subscribe
Otsuka ABILIFY ASIMTUFII aripiprazole SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 217006-002 Apr 27, 2023 RX Yes Yes 11,097,007 ⤷  Subscribe Y MAINTENANCE MONOTHERAPY TREATMENT OF BIPOLAR I DISORDER ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,097,007

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 090776 ⤷  Subscribe
Argentina 126033 ⤷  Subscribe
Australia 2013253374 ⤷  Subscribe
Australia 2017228608 ⤷  Subscribe
Australia 2019200060 ⤷  Subscribe
Australia 2020204200 ⤷  Subscribe
Australia 2022241491 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.